Personal tools

Coexpression cluster:C263

From FANTOM5_SSTAR

Revision as of 17:37, 18 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C263_cervical_keratoacanthoma_tongue_skin_esophagus_throat_tonsil



Phase1 CAGE Peaks

Hg19::chr10:62029969..62029974,-p@chr10:62029969..62029974
-
Hg19::chr10:62029985..62029992,-p@chr10:62029985..62029992
-
Hg19::chr10:62030063..62030071,-p@chr10:62030063..62030071
-
Hg19::chr10:62030084..62030091,-p@chr10:62030084..62030091
-
Hg19::chr11:20075386..20075404,+p@chr11:20075386..20075404
+
Hg19::chr11:20075419..20075431,+p@chr11:20075419..20075431
+
Hg19::chr12:52779433..52779437,-p1@KRT84
Hg19::chr12:966066..966072,+p@chr12:966066..966072
+
Hg19::chr12:966094..966103,+p@chr12:966094..966103
+
Hg19::chr13:20805611..20805619,-p6@GJB6
Hg19::chr14:23607321..23607333,-p29@SLC7A8
Hg19::chr17:26833250..26833262,+p2@FOXN1
Hg19::chr17:26833339..26833378,+p1@FOXN1
Hg19::chr17:39150341..39150346,-p2@KRTAP3-3
Hg19::chr17:39150411..39150417,-p1@KRTAP3-3
Hg19::chr17:39659057..39659078,-p3@KRT13
Hg19::chr17:39659081..39659098,-p9@KRT13
Hg19::chr17:39659118..39659129,-p10@KRT13
Hg19::chr17:39659818..39659840,-p@chr17:39659818..39659840
-
Hg19::chr17:39661984..39661995,-p7@KRT13
Hg19::chr17:39662068..39662109,-p12@KRT13
Hg19::chr17:39728303..39728318,-p1@KRT9
Hg19::chr17:72931876..72931881,+p3@OTOP3
Hg19::chr17:7990855..7990862,-p3@ALOX12B
Hg19::chr17:7990883..7990893,-p5@ALOX12B
Hg19::chr17:7990909..7990918,-p6@ALOX12B
Hg19::chr18:45553476..45553478,-p@chr18:45553476..45553478
-
Hg19::chr19:36640447..36640459,+p@chr19:36640447..36640459
+
Hg19::chr19:46753477..46753483,-p@chr19:46753477..46753483
-
Hg19::chr19:46753484..46753496,-p@chr19:46753484..46753496
-
Hg19::chr1:153371709..153371712,-p@chr1:153371709..153371712
-
Hg19::chr1:17767804..17767822,-p@chr1:17767804..17767822
-
Hg19::chr1:90320845..90320886,-p@chr1:90320845..90320886
-
Hg19::chr20:2361545..2361557,+p1@TGM6
Hg19::chr21:31744583..31744589,-p1@KRTAP13-2
Hg19::chr2:165706192..165706200,+p@chr2:165706192..165706200
+
Hg19::chr2:56150507..56150564,-p4@EFEMP1
Hg19::chr3:185016843..185016846,+p@chr3:185016843..185016846
+
Hg19::chr5:134907473..134907482,+p@chr5:134907473..134907482
+
Hg19::chr5:160356310..160356324,-p@chr5:160356310..160356324
-
Hg19::chr5:160356347..160356372,-p@chr5:160356347..160356372
-
Hg19::chr5:160356399..160356409,-p@chr5:160356399..160356409
-
Hg19::chr5:160356414..160356417,-p@chr5:160356414..160356417
-
Hg19::chr5:160356450..160356459,-p@chr5:160356450..160356459
-
Hg19::chr7:101448101..101448113,+p@chr7:101448101..101448113
+
Hg19::chr7:101448176..101448184,+p@chr7:101448176..101448184
+
Hg19::chr7:101448204..101448229,+p@chr7:101448204..101448229
+
Hg19::chr7:101448249..101448254,+p@chr7:101448249..101448254
+
Hg19::chr7:101448277..101448287,+p@chr7:101448277..101448287
+
Hg19::chr9:139090625..139090662,-p@chr9:139090625..139090662
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005882intermediate filament1.12724880080687e-06
GO:0045111intermediate filament cytoskeleton1.12724880080687e-06
GO:0008544epidermis development7.33232629180967e-06
GO:0007398ectoderm development7.53279374665983e-06
GO:0009888tissue development0.000113812529658966
GO:0044430cytoskeletal part0.000306808810804164
GO:0048513organ development0.000751760056303848
GO:0005856cytoskeleton0.0018540601394571
GO:0048731system development0.00297438690637043
GO:0048856anatomical structure development0.00697556275241885
GO:0005200structural constituent of cytoskeleton0.00697556275241885
GO:0004052arachidonate 12-lipoxygenase activity0.0109894317719929
GO:0007275multicellular organismal development0.0109894317719929
GO:0032501multicellular organismal process0.0139250229803728
GO:0045109intermediate filament organization0.0224745487659294
GO:0043588skin development0.0234652206207304
GO:0043232intracellular non-membrane-bound organelle0.0234652206207304
GO:0043228non-membrane-bound organelle0.0234652206207304
GO:0030280structural constituent of epidermis0.0354574183313179
GO:0032502developmental process0.0384841652726446
GO:0016165lipoxygenase activity0.0384841652726446
GO:0045104intermediate filament cytoskeleton organization and biogenesis0.0403887581209315
GO:0003810protein-glutamine gamma-glutamyltransferase activity0.0403887581209315
GO:0045103intermediate filament-based process0.0403887581209315
GO:0015804neutral amino acid transport0.0403887581209315
GO:0015175neutral amino acid transmembrane transporter activity0.0439991467351504
GO:0042605peptide antigen binding0.0448546158351321
GO:0009887organ morphogenesis0.0475044895154243
GO:0043450alkene biosynthetic process0.0493081523095328
GO:0019370leukotriene biosynthetic process0.0493081523095328



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.